ZA95908B - A synergistic formulation for treatment of rheumatic diseases - Google Patents
A synergistic formulation for treatment of rheumatic diseasesInfo
- Publication number
- ZA95908B ZA95908B ZA95908A ZA95908A ZA95908B ZA 95908 B ZA95908 B ZA 95908B ZA 95908 A ZA95908 A ZA 95908A ZA 95908 A ZA95908 A ZA 95908A ZA 95908 B ZA95908 B ZA 95908B
- Authority
- ZA
- South Africa
- Prior art keywords
- treatment
- rheumatic diseases
- synergistic formulation
- synergistic
- formulation
- Prior art date
Links
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA95908A ZA95908B (en) | 1995-02-06 | 1995-02-06 | A synergistic formulation for treatment of rheumatic diseases |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ZA95908A ZA95908B (en) | 1995-02-06 | 1995-02-06 | A synergistic formulation for treatment of rheumatic diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA95908B true ZA95908B (en) | 1995-10-13 |
Family
ID=25584796
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA95908A ZA95908B (en) | 1995-02-06 | 1995-02-06 | A synergistic formulation for treatment of rheumatic diseases |
Country Status (1)
Country | Link |
---|---|
ZA (1) | ZA95908B (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638540B2 (en) | 1997-05-06 | 2003-10-28 | Universitat Bern | Plant extracts for the treatment of increased bone resorption |
US7141253B2 (en) * | 2002-11-14 | 2006-11-28 | Board Of Trustees Of Michigan State University | Cyclooxygenase-2 inhibitory withanolide compositions and method |
US20090060883A1 (en) * | 2001-12-11 | 2009-03-05 | Nestec S.A. | Composition for promotion of bone growth and maintenance of bone health |
US20120021077A1 (en) * | 2007-07-18 | 2012-01-26 | Bhushan Patwardhan | Synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds) |
CN104853761A (en) * | 2012-10-23 | 2015-08-19 | 皮拉马尔企业有限公司 | Herbal composition for the prevention and treatment of tnf-alpha mediated diseases |
-
1995
- 1995-02-06 ZA ZA95908A patent/ZA95908B/en unknown
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6638540B2 (en) | 1997-05-06 | 2003-10-28 | Universitat Bern | Plant extracts for the treatment of increased bone resorption |
US20090060883A1 (en) * | 2001-12-11 | 2009-03-05 | Nestec S.A. | Composition for promotion of bone growth and maintenance of bone health |
US7141253B2 (en) * | 2002-11-14 | 2006-11-28 | Board Of Trustees Of Michigan State University | Cyclooxygenase-2 inhibitory withanolide compositions and method |
US7195784B2 (en) * | 2002-11-14 | 2007-03-27 | Board Of Trustees Of Michigan State University | Cyclooxygenase-2 inhibitory withanolide compositions and method |
US20120021077A1 (en) * | 2007-07-18 | 2012-01-26 | Bhushan Patwardhan | Synergistic herbal composition for treatment of rheumatic and musculo-skeletal disorders (rmsds) |
CN104853761A (en) * | 2012-10-23 | 2015-08-19 | 皮拉马尔企业有限公司 | Herbal composition for the prevention and treatment of tnf-alpha mediated diseases |
US20150265651A1 (en) * | 2012-10-23 | 2015-09-24 | Piramal Enterprises Limited | Herbal Composition for the Prevention and Treatment of TNF-ALPHA Mediated Diseases |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0831845A4 (en) | Diphosphonate derivatives of therapeutic agents | |
HK1009939A1 (en) | Medicament for treating cardiac inflammatory diseases | |
AU5178296A (en) | Induction of e-selectin for targetting therapeutic agents | |
AU7715491A (en) | A therapeutic preparation containing myrrh for treating skin disorders | |
IL119894A (en) | Use of thiazolidine in the preparation of a medicament for the treatment of osteoporosis | |
AU2027695A (en) | Pharmaceutical composition for treating stoma-peripheral inflammation diseases | |
PL310348A1 (en) | Substituted derivatives of azolone for use in treating diseases caused by heliobacter | |
HUP9900147A2 (en) | Therapeutic agents and pharmaceutical compositions for treatment of autoimmune diseases | |
HUP9901303A3 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
ZA95908B (en) | A synergistic formulation for treatment of rheumatic diseases | |
EP0765661A3 (en) | Use of docosahexaenoic acid for the manufacture of a medicament for the treatment of glumerulonephritis | |
AU3263795A (en) | Medicament for treatment or prophylaxis of incontinence | |
AU6460696A (en) | Use of n-cyclohexyl benzamides for treating bowel disorders | |
AU697136B2 (en) | Agents for treating metabolic bone diseases | |
AU4819993A (en) | Drug for treatment and prophylaxis of bone and joint diseases | |
IL109235A0 (en) | Pharmaceutical compositions containing ureido derivatives for the treatment of lentivirus-induced diseases | |
IL117465A (en) | Use of certain cystine derivatives for the preparation of a medicament for the treatment of restenosis | |
ZA944671B (en) | Medicaments for the treatment of inflammatory diseases | |
HUP0104619A3 (en) | Use of pde inhibitors in the manufacture of a medicament for the treatment of bladder diseases | |
AU9166598A (en) | Use of sulphonanilide derivatives to obtain a medicine for treating retrograde ejaculation or aspermia | |
GB9523066D0 (en) | Compounds and their therapeutic use | |
GB2266241B (en) | Treatment of pastures | |
SI0858337T1 (en) | A pharmaceutical composition for the treatment of autoimmune diseases | |
AU7340894A (en) | Treatment of oral ailments | |
IL107493A0 (en) | A device and method for the treatment of rheumatic diseases |